Literature DB >> 30014296

Research Progresses in Cancer Stem Cells of Three Common Fertility-Related Female Malignancies.

Xi-Ping Zhang1, Qi-Hui Cheng2, Hong-Jian Yang3, En-Qi Qiao3.   

Abstract

With abilities to renew themselves and lead to heterogeneity of tumors, cancer stem cells (CSCs) are similar to stem cells. As three leading causes of death that endanger women's health, breast cancer, ovarian cancer and cervical cancer are characterized by high degree of malignancy, metastasis and recurrence. Associated with women's fertility, these three malignancies are common and representative among females. These years, research findings have suggested that CSCs are closely connected with many cancers (including aforementioned three malignancies) and several processes of tumors such as their genesis and development. CSCs have become great concerns for current cancer treatment and interventions. This paper does not only summarize roles of CSCs in genesis, development, drug resistance, metastasis and recurrence of breast cancer, ovarian cancer and cervical cancer, but also proposes potential methods of treatment and intervention, in hope of inspiring readers and researchers.

Entities:  

Keywords:  Breast Cancer; Cancer stem cells; Cervical Cancer; Female; Malignant tumors; Ovarian Cancer

Mesh:

Year:  2018        PMID: 30014296     DOI: 10.1007/s12253-018-0448-y

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  42 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

2.  Hiwi facilitates chemoresistance as a cancer stem cell marker in cervical cancer.

Authors:  Wei Liu; Qing Gao; Kunlun Chen; Xiang Xue; Mu Li; Qian Chen; Gaixia Zhu; Ya Gao
Journal:  Oncol Rep       Date:  2014-08-13       Impact factor: 3.906

3.  TRX-E-002-1 Induces c-Jun-Dependent Apoptosis in Ovarian Cancer Stem Cells and Prevents Recurrence In Vivo.

Authors:  Ayesha B Alvero; Andrew Heaton; Eydis Lima; Mary Pitruzzello; Natalia Sumi; Yang Yang-Hartwich; Carlos Cardenas; Sahra Steinmacher; Dan-Arin Silasi; David Brown; Gil Mor
Journal:  Mol Cancer Ther       Date:  2016-04-08       Impact factor: 6.261

4.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

5.  Clinical significance of Gremlin 1 in cervical cancer and its effects on cancer stem cell maintenance.

Authors:  Masakazu Sato; Kei Kawana; Asaha Fujimoto; Mitsuyo Yoshida; Hiroe Nakamura; Haruka Nishida; Tomoko Inoue; Ayumi Taguchi; Juri Takahashi; Katsuyuki Adachi; Kazunori Nagasaka; Yoko Matsumoto; Osamu Wada-Hiraike; Katsutoshi Oda; Yutaka Osuga; Tomoyuki Fujii
Journal:  Oncol Rep       Date:  2015-10-30       Impact factor: 3.906

6.  Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer.

Authors:  Karina Dahl Steffensen; Ayesha B Alvero; Yang Yang; Marianne Waldstrøm; Pei Hui; Jennie C Holmberg; Dan-Arin Silasi; Anders Jakobsen; Thomas Rutherford; Gil Mor
Journal:  J Oncol       Date:  2011-08-29       Impact factor: 4.375

7.  Downregulated lincRNA HOTAIR expression in ovarian cancer stem cells decreases its tumorgeniesis and metastasis by inhibiting epithelial-mesenchymal transition.

Authors:  Jing Wang; Dengyu Chen; Xiangfeng He; Yuxia Zhang; Fangfang Shi; Di Wu; Junsong Chen; Ying Zhang; Fengsu Zhao; Jun Dou
Journal:  Cancer Cell Int       Date:  2015-02-25       Impact factor: 5.722

8.  Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin.

Authors:  Wei-Ching Chen; Hui-Ping Hsu; Chung-Yen Li; Ya-Ju Yang; Yu-Hsuan Hung; Chien-Yu Cho; Chih-Yang Wang; Tzu-Yang Weng; Ming-Derg Lai
Journal:  Int J Oncol       Date:  2016-09-15       Impact factor: 5.650

9.  Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.

Authors:  Suling Liu; Yang Cong; Dong Wang; Yu Sun; Lu Deng; Yajing Liu; Rachel Martin-Trevino; Li Shang; Sean P McDermott; Melissa D Landis; Suhyung Hong; April Adams; Rosemarie D'Angelo; Christophe Ginestier; Emmanuelle Charafe-Jauffret; Shawn G Clouthier; Daniel Birnbaum; Stephen T Wong; Ming Zhan; Jenny C Chang; Max S Wicha
Journal:  Stem Cell Reports       Date:  2013-12-27       Impact factor: 7.765

10.  Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer.

Authors:  A E Witt; C-W Lee; T I Lee; D J Azzam; B Wang; C Caslini; F Petrocca; J Grosso; M Jones; E B Cohick; A B Gropper; C Wahlestedt; A L Richardson; R Shiekhattar; R A Young; T A Ince
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.